AstraZeneca

In News

Cell therapy biotech shares first clinical data for in vivo CAR-T that attracted $1B AstraZeneca acquisition - Fierce Biotech

Fierce Biotech - Jul 07, 2025

Amid $15B AstraZeneca partnership rumor, Summit needs $7.7B upfront to excite investors: analyst - Fierce Pharma

Fierce Pharma - Jul 07, 2025

Summit Therapeutics Reportedly Makes $15B AstraZeneca Licensing Talks for Lung Cancer Drug - Yahoo Finance

Yahoo Finance - Jul 06, 2025

Top Chinese oncologist and director of Jilin Cancer Hospital, Cheng Ying, dies - South China Morning Post

South China Morning Post - Jul 09, 2025

AstraZeneca's newest CAR-T play shows first glimpse of clinical activity - FirstWord Pharma

FirstWord Pharma - Jul 07, 2025

AstraZeneca: Just What The Doctor Ordered (NASDAQ:AZN) - Seeking Alpha

Seeking Alpha - Jul 08, 2025

AstraZeneca’s Tozorakimab Study: A New Phase in Drug Delivery - TipRanks

TipRanks - Jul 08, 2025

Dizal to challenge J&J with FDA approval for lung cancer drug Zegfrovy - Fierce Pharma

Fierce Pharma - Jul 07, 2025

AstraZeneca inks third deal with JCR, this time to improve delivery of gene therapies - FirstWord Pharma

FirstWord Pharma - Jul 08, 2025

SMMT Stock Gains on Rumored Licensing Talks With AstraZeneca - Yahoo Finance

Yahoo Finance - Jul 07, 2025

Top Analyst Reports for T-Mobile, AstraZeneca & Comcast - Yahoo Finance

Yahoo Finance - Jul 08, 2025

‘Rare Buy Signal’ Sparks Reversal Hopes in AstraZeneca Stock (AZN) - TipRanks

TipRanks - Jul 09, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.